![](https://cdn.prod.website-files.com/64274c1f7e0d98ad310e249a/664630c9a2cfa43c7f06749a_3854902-662bd7aa9bb54.jpeg)
Mohammed Ahmed
Mohammed is Founder & Managing Partner of Chiltern Street Capital, a global asset manager that invests in technology-enabled businesses across Global Emerging Markets
Mohammed is a venture and growth equity investor and was most recently at SoftBank’s $100B Vision Fund, where he focused on Portfolio Management, Capital Formation and Investor Relations. Prior to this, Mohammed built and scaled an Education SaaS business in the UK, with a roster of global clients
He started his career in investment banking at Barclays Investment Bank in London, advising central bank and sovereign wealth fund clients on portfolio diversification within the capital markets and on asset allocation into alternatives. He originated, structured and executed on a number of one-off macro level transactions aimed at helping his sovereign clients hedge their economic and macro risk. He culminated his career at Barclays as Head of Emerging Markets for Sovereign Wealth Funds
Mohammed sits on the Executive Advisory Board of Prostate Cancer Research, the only charity that focuses solely on the advanced stage of the disease, which causes the majority of prostate cancer deaths and for which treatments are currently limited. Mohammed is also an Advisor and mentor to a handful of companies and their CEOs across the globe, spanning technology firms in Emerging Markets, to brick-and-mortar businesses in Developed Markets
Mohammed is a Kauffman Fellow, and holds an MBA from INSEAD, where he was the 2015 Class Valedictorian. He has a BA (with Honours) and MA (Oxon) from the University of Oxford, where he read Modern Languages (Russian) & Oriental Studies (Arabic), prior to which he was educated at Eton College in the UK